SAN ANTONIO, Sept. 23, 2014 /PRNewswire/ -- United Allergy Services (UAS)®, the leading healthcare services company empowering physicians and health systems to deliver safe and effective allergy testing and customized immunotherapy services, today announced that Kevin Johnson has joined the company as Chief Executive Officer.
Paul A. Bell, UAS Board of Directors Chairman, says "Kevin has been involved with our company as a board member for almost two years. He has had a very successful career with Quest Diagnostics and DIANON Systems, leaders in clinical laboratory services and cancer diagnostics. His excellent track record building sales and operational excellence will be critically important to UAS as the business continues to grow rapidly and mature."
Johnson succeeds Nicolas Hollis as Chief Executive Officer. Hollis will take a strategic and governance role as UAS Board of Directors Vice Chairman. "We are indebted to Nick Hollis for his tremendous contribution to United Allergy Services. His vision and leadership drove the exponential growth and success of UAS over the last five years," said Bell.
"I am excited to join United Allergy Services as Chief Executive Officer," said Johnson. "The company has assembled an incredibly talented and focused management team to deliver vital allergy services through primary care physician practices. I believe my years of experience in leading the provision of diagnostic testing services to thousands of physicians and millions of patients throughout the country will enable me to bring helpful insights to the company as we continue our rapid expansion nationwide. I look forward to leading UAS through our next stage of growth."
"UAS is a healthcare services organization that partners with primary care physicians by providing a highly skilled and trained professional to work under the supervision of the physician to test and treat patients who suffer from allergies," says Nicolas Hollis, Vice Chairman of the Board. "United Allergy Services has the most comprehensive and professional support organization in the industry, ensuring the highest level of safety, effectiveness, and patient convenience. Kevin brings a wide range of expertise in all areas of operational excellence that are vital to UAS and our partner providers."
Johnson has more than 30 years of experience with healthcare diagnostic laboratories, including executive leadership positions with Quest Diagnostics, Inc. and DIANON Systems, Inc.
During his 18 years with Quest Diagnostics, Johnson held numerous management and executive level positions. In 1996, Johnson joined DIANON Systems, Inc., the preeminent cancer diagnostic services company offering specialized anatomic pathology and molecular genetic testing services to physicians nationwide. He served as President, CEO and Chairman of the Board for DIANON Systems, Inc. until January 2003, when the company was acquired by Laboratory Corporation of America. Currently, Johnson serves on the Boards of NeoGenomics, Inc. and ClearPath Diagnostics, a private company.
September 23, 2014